These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2688414)

  • 21. Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus.
    Garvey WT; Huecksteadt TP; Matthaei S; Olefsky JM
    J Clin Invest; 1988 May; 81(5):1528-36. PubMed ID: 3366906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postprandial changes in cytosolic free calcium and glucose uptake in adipocytes in obesity and non-insulin-dependent diabetes mellitus.
    Segal S; Lloyd S; Sherman N; Sussman K; Draznin B
    Horm Res; 1990; 34(1):39-44. PubMed ID: 2074090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postprandial oscillatory patterns of blood glucose and insulin in NIDDM. Abnormal diurnal insulin secretion patterns and glucose homeostasis independent of obesity.
    Calles-Escandon J; Jaspan J; Robbins DC
    Diabetes Care; 1989; 12(10):709-14. PubMed ID: 2693010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus.
    Kashiwagi A; Verso MA; Andrews J; Vasquez B; Reaven G; Foley JE
    J Clin Invest; 1983 Oct; 72(4):1246-54. PubMed ID: 6355180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Responsiveness of parathyroid hormone secretion to a phosphate load in hypertensive patients with non insulin dependent diabetes mellitus].
    Irzyniec T
    Endokrynol Pol; 2009; 60(3):180-8. PubMed ID: 19569018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular defects in glucose metabolism in obese patients with NIDDM.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of associated conditions on glycemic control of NIDDM patients.
    Ferrannini E; Stern MP; Galvan AQ; Mitchell BD; Haffner SM
    Diabetes Care; 1992 Apr; 15(4):508-14. PubMed ID: 1499466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes mellitus, hypertension and ageing: the ionic hypothesis of ageing and cardiovascular-metabolic diseases.
    Barbagallo M; Resnick LM; Dominguez LJ; Licata G
    Diabetes Metab; 1997 Sep; 23(4):281-94. PubMed ID: 9342541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance and hypertension.
    Sowers JR
    Mol Cell Endocrinol; 1990 Dec; 74(2):C87-9. PubMed ID: 2090512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction.
    Gumbiner B; Van Cauter E; Beltz WF; Ditzler TM; Griver K; Polonsky KS; Henry RR
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2061-8. PubMed ID: 8964829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in calcium and magnesium levels of lymphocytes in patients with diabetes and hypertension].
    Mo Z; Zhang M; Guan Y; Jian W
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(5):471-3. PubMed ID: 12080688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
    McMahon M; Marsh HM; Rizza RA
    Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects.
    Feher MD; Henderson AD; Wadsworth J; Poulter C; Gelding S; Richmond W; Sever PS; Elkeles RS
    J Hum Hypertens; 1990 Oct; 4(5):571-7. PubMed ID: 1980930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased platelet cytosolic calcium responses to low density lipoprotein in type II diabetes with and without hypertension.
    Standley PR; Ali S; Bapna C; Sowers JR
    Am J Hypertens; 1993 Nov; 6(11 Pt 1):938-43. PubMed ID: 8305168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular ions in hypertension, insulin resistance, obesity, and diabetes: a unifying theme.
    Resnick LM
    J Am Soc Nephrol; 1992 Oct; 3(4 Suppl):S78-85. PubMed ID: 1457764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes and hypertension.
    Mahler RJ
    Horm Metab Res; 1990 Dec; 22(12):599-607. PubMed ID: 2076856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular ions in hypertension, diabetes, and obesity. A nuclear magnetic resonance spectroscopic study.
    Resnick LM; Gupta RK; Bhargava KK; Gruenspan H; Alderman MH; Laragh JH
    Hypertension; 1991 Jun; 17(6 Pt 2):951-7. PubMed ID: 2045175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertension, hyperlipidemia, and abdominal obesity and the development of microalbuminuria in patients with non-insulin-dependent diabetes mellitus.
    Spangler JG; Konen JC
    J Am Board Fam Pract; 1996; 9(1):1-6. PubMed ID: 8770803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: relationship to hypertension.
    Iannello S; Campione R; Belfiore F
    Mol Genet Metab; 1998 Mar; 63(3):214-23. PubMed ID: 9608544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM).
    Chan JC; Cheung CK; Swaminathan R; Nicholls MG; Cockram CS
    Postgrad Med J; 1993 Mar; 69(809):204-10. PubMed ID: 8497435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.